Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) — Cash Flow Reinvestment Rate
Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a Cash Flow Reinvestment Rate of 0.16x as of September 2025, reinvesting NT$17.89 Million (capex NT$9.20 Million plus investments NT$-8.69 Million) from operating cash flow of NT$112.62 Million. Explore 1762 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chunghwa Chemical Synthesis & Biotech Co Ltd Cash Flow Reinvestment Rate (2008–2025)
Historical reinvestment intensity for Chunghwa Chemical Synthesis & Biotech Co Ltd across 17 annual periods. Also explore Chunghwa Chemical Synthesis & Biotech Co assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2025)
Year-by-year capital reinvestment analysis for Chunghwa Chemical Synthesis & Biotech Co Ltd. For live market cap and broader valuation context, see 1762 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | NT$62.33 Million | NT$142.61 Million | NT$62.33 Million | ▼ -0.2% |
| 2024 | 0.44x | NT$204.79 Million | NT$467.65 Million | NT$104.69 Million | ▼ -57.3% |
| 2022 | 1.03x | NT$752.37 Million | NT$733.78 Million | NT$376.18 Million | ▼ -72.1% |
| 2021 | 3.67x | NT$805.41 Million | NT$219.18 Million | NT$405.45 Million | ▼ -14.3% |
| 2020 | 4.29x | NT$592.94 Million | NT$138.24 Million | NT$192.98 Million | ▲ +353.1% |
| 2019 | 0.95x | NT$253.84 Million | NT$268.13 Million | NT$114.80 Million | ▼ -33.3% |
| 2018 | 1.42x | NT$332.97 Million | NT$234.66 Million | NT$93.73 Million | ▼ -72.7% |
| 2017 | 5.19x | NT$827.48 Million | NT$159.34 Million | NT$805.80 Million | ▲ +450.9% |
| 2016 | 0.94x | NT$246.34 Million | NT$261.31 Million | NT$114.86 Million | ▼ -48.1% |
| 2015 | 1.82x | NT$144.87 Million | NT$79.70 Million | NT$129.28 Million | ▼ -74.0% |
| 2014 | 7.00x | NT$161.59 Million | NT$23.08 Million | NT$146.59 Million | ▲ +748.2% |
| 2013 | 0.83x | NT$119.88 Million | NT$145.24 Million | NT$110.04 Million | ▼ -71.0% |
| 2012 | 2.84x | NT$762.95 Million | NT$268.46 Million | NT$762.95 Million | ▲ +513.3% |
| 2011 | 0.46x | NT$67.12 Million | NT$144.84 Million | NT$67.12 Million | ▲ +148.0% |
| 2010 | 0.19x | NT$51.50 Million | NT$275.61 Million | NT$51.50 Million | ▲ +136.2% |
| 2009 | 0.08x | NT$36.55 Million | NT$462.07 Million | NT$36.55 Million | ▼ -85.8% |
| 2008 | 0.56x | NT$42.12 Million | NT$75.39 Million | NT$42.12 Million | — |